David McClung
CIK 1686155 · Chief Financial Officer · last filed 2026-07-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$89.3K
Companies
2
Total Filings
28
Lifetime Open-Market Net
$53.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCDA | Chief Financial Officer | 114,245 | $0.78 | $89.3K | $49.8K | 13 | 2026-07-07 |
| BioCardia, Inc. (BCDAW) Delisted | Chief Financial Officer | 135,724 | $0.01 | $828 | $4.1K | 15 | 2023-06-26 |
Recent Filings · Page 2 of 3
28 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-07 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | −17,347 | -$22.9K | EDGAR |
| 2022-12-19 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +8,928 | $15.0K | EDGAR |
| 2022-10-11 | BioCardia, Inc. (BCDAW) Delisted | Buy (P) | +2,000 | $4.1K | EDGAR |
| 2022-05-18 | BioCardia, Inc. (BCDAW) Delisted | Tax (F) | −20,632 | -$27.2K | EDGAR |
| 2022-04-18 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +50,345 | $0 | EDGAR |
| 2021-06-11 | BioCardia, Inc. (BCDAW) Delisted | Tax (F) | −7,274 | -$31.6K | EDGAR |
| 2021-04-27 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | −21,370 | $0 | EDGAR |
| 2020-07-01 | BioCardia, Inc. (BCDAW) Delisted | Tax (F) | −7,895 | -$18.9K | EDGAR |
| 2020-04-29 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +19,312 | $0 | EDGAR |
| 2020-04-28 | BioCardia, Inc. (BCDAW) Delisted | Grant (A) | +19,312 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.